Patent details

LUC50020 Product Name: Lécanémab

Basic Information

Publication number:
LUC50020
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP077479657
Legal Status:
Pending & Published
Application number:
LUC50020
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/24/1891
Marketing Authorization Type:
Marketing Authorization Date:
15/04/2025
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
04/09/2025
First Marketing Authorization date:
15/04/2025
Grant date:
Activation date:
Publication date:
09/09/2025
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
23/03/2032
SPC Extension Expiration:
23/03/2032
Rejection date:
Withdrawal date:

Owner

From:
04/09/2025
 
 

Name:
BIOARCTIC AB
Address:
Warfvinges väg 35, S-112 51, STOCKHOLM , Sweden (SE)

Agent

Name:
ARONOVA S.A.
From:
04/09/2025
Address:
PO Box 327, L-4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
To:

Publication

Bulletin

Bulletin Heading:
SPC1
Bulletin edition number:
2025/11
Publication date:
02/10/2025
Description:
Section C : Published requests for Supplementary Protection Certificates – I1 publication

Annual Fees

Annual Fee Due Date:
31/03/2027
Annual Fee Number:
21
Annual Fee Amount:
410 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
04/09/2025 Outgoing Correspondence 3
04/09/2025 General Document 3
04/09/2025 General Document 2
04/09/2025 General Document 3
04/09/2025 General Document 2
04/09/2025 General Document 34
04/09/2025 General Document 1
04/09/2025 General Document 11
04/09/2025 General Document 1
04/09/2025 Application Form 5
04/09/2025 MA publication 11
09/09/2025 Outgoing Correspondence 1
09/09/2025 Publication 1